Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Surgical Sealants and Adhesives Market Forecast 2035 | Fibrin Sealants, Cyanoacrylate Tissue Adhesives, Polyethylene Glycol Hydrogel Sealants, Albumin-Glutaraldehyde Adhesives & Haemostatic Sealants for Surgical Wound Closure, Haemostasis, Tissue Sealing & Anastomosis in Cardiac, Thoracic, Orthopaedic & Laparoscopic Surgery

The surgical sealants and adhesives market encompasses fibrin sealants (thrombin-fibrinogen), polyethylene glycol (PEG) hydrogel sealants, cyanoacrylate tissue adhesives, albumin-glutaraldehyde bioadhesives, collagen and gelatin haemostatic sealants, synthetic polymer tissue adhesives, and advanced wound closure systems for haemostasis, air and fluid leak prevention, tissue bonding, and wound closure in cardiovascular, thoracic, laparoscopic, orthopaedic, and neurological surgery. The global surgical sealants and adhesives market is projected to reach USD 4.6 billion by 2035 at a 8.2% CAGR, driven by minimally invasive surgery growth driving demand for laparoscopic haemostatic and tissue sealant products, cardiac surgery sealant demand growing with TAVI and open-heart procedure volume, and surgical adhesive replacing sutures and staples in wound closure for faster procedure time and reduced post-operative complication.

Surgical sealants and adhesives are among the highest-value per gram materials in any manufacturing or healthcare context: Baxter’s Tisseel fibrin sealant sells for USD 300-1,500 per kit, and the clinical value it delivers — achieving haemostasis in a cardiac surgery field in seconds rather than minutes of additional suturing time — justifies that premium relative to the cost of extended operating time. Fibrin sealant haemostasis is the gold standard in cardiovascular surgery because fibrin (derived from pooled human plasma or recombinant sources) replicates the final stage of the natural coagulation cascade, forming a fibrin clot at the application site within 60-120 seconds that is fully biocompatible and biodegradable over 10-14 days as wound healing progresses.

Executive Snapshot

What is the surgical sealants and adhesives market?
The surgical sealants and adhesives market encompasses fibrin sealants, PEG hydrogel sealants, cyanoacrylate tissue adhesives, albumin-glutaraldehyde bioadhesives, and haemostatic sealants for haemostasis, tissue sealing, air and fluid leak prevention, and wound closure in surgical procedures.

What is driving surgical sealants and adhesives market growth?
Minimally invasive surgery growth driving laparoscopic tissue sealant demand; cardiac surgery sealant growing with TAVI and open-heart procedure volume; surgical adhesive replacing sutures for faster wound closure; and robotic surgery adoption driving precision tissue sealant application.

What are the main surgical sealant types and their applications?
Fibrin sealants achieve haemostasis in cardiovascular, liver, and spleen surgery; PEG hydrogel sealants prevent cerebrospinal fluid leak in spine and brain surgery and air leak after pulmonary resection; cyanoacrylate tissue adhesives close skin lacerations and laparoscopic port sites; and albumin-glutaraldehyde adhesives (BioGlue) provide structural tissue bonding in aortic dissection and cardiovascular reconstruction, where the adhesive must reinforce the aortic wall during repair.

How do surgical sealants replace sutures and what are the clinical benefits?
Surgical tissue adhesives and sealants close tissue by bonding the wound edges or reinforcing suture lines without penetrating the tissue with needle and thread. Clinical benefits include 2-5 minute wound closure versus 15-30 minute suturing, no suture removal visit, reduced infection risk from percutaneous wound access, and superior cosmetic outcome for paediatric and facial wounds. Cyanoacrylate tissue adhesive has equivalent wound closure strength to subcuticular sutures in randomised controlled trials for uncomplicated lacerations.

Which regions lead the surgical sealants market?
North America leads at 40% driven by US healthcare expenditure, surgical procedure volume, and advanced wound closure adoption in hospitals; Europe is the second-largest market driven by cardiovascular surgery sealant adoption and laparoscopic procedure volume; Asia-Pacific is growing driven by China and India surgical infrastructure expansion.

What does the surgical sealants and adhesives market look like in 2035?
Biosynthetic hydrogel sealants replace animal-derived fibrin sealants in preference by surgeons seeking non-plasma-derived alternatives; robotic surgery precision tissue sealant application enables consistent dosing; and next-generation bio-inspired surgical adhesives wet-tissue adhesion at mussel-protein-inspired chemistry levels.

Request Sample
Speak with an Analyst
Download TOC

Market Dynamics: Surgical Sealants and Adhesives Market

The structural forces reshaping the surgical sealants and adhesives market — what manufacturers, biomaterial suppliers, healthcare providers, medical device companies, regulatory stakeholders, and investors must understand.

  • Minimally Invasive Surgery Growth Driving Laparoscopic Haemostatic Sealant and Tissue Adhesive Demand:Laparoscopic cholecystectomy, appendectomy, hernia repair, and gynaecological MIS procedure volume driving haemostatic sealant, mesh fixation tissue adhesive, and laparoscopic tissue sealant demand are driving MIS surgical sealant demand from Baxter, Ethicon, Medtronic, and laparoscopic sealant supply.
  • Cardiovascular Surgery Sealant Growing with TAVI, Coronary Artery Bypass, and Aortic Reconstruction Volume:Cardiac TAVI transcatheter valve replacement, CABG, and aortic reconstruction procedure driving fibrin sealant, albumin-glutaraldehyde, and synthetic polymer cardiac sealant demand are driving cardiovascular surgery sealant demand from Baxter Tisseel, CryoLife BioGlue, and cardiac sealant supply.
  • Pulmonary Surgery Air Leak Prevention Driving PEG Hydrogel Sealant Demand in Lung Resection:Pulmonary lobectomy and wedge resection air leak prevention driving PEG hydrogel sealant (Covidien Progel, Cohesion TissuePatch) demand for lung parenchyma sealing are driving pulmonary air leak sealant demand from Cohesion, Baxter, and pulmonary sealant supply.
  • Spine and Neurosurgery CSF Leak Prevention Driving PEG Sealant Demand in Dural Closure Application:Spinal dural repair and neurosurgical dural closure CSF leak prevention driving DuraSeal PEG hydrogel sealant demand at spinal and brain surgery procedures are driving dural closure sealant demand from Integra, Baxter, and dural sealant supply.
  • Topical Skin Closure Adhesive Replacing Sutures and Staples in Emergency and Elective Wound Closure:Emergency department laceration, surgical port site, and elective incision closure using cyanoacrylate tissue adhesive replacing sutures and staples for fast, no-visit wound closure are driving tissue adhesive wound closure demand from Ethicon Dermabond, Closure Medical, Chemence, and tissue adhesive supply.
  • Robotic Surgery Precision Tissue Sealant Application Growing with Da Vinci and Emerging Robotic Platform:Robotic surgery da Vinci platform haemostatic sealant and tissue adhesive endoscopic applicator growing with robotic procedure adoption in urology, gynaecology, and thoracic surgery are driving robotic surgery sealant demand from Baxter, Ethicon, and robotics-compatible sealant supply.

Market Segmentation: Surgical Sealants and Adhesives Market

By Type
  • Natural or Biological Adhesives and Sealants
    • Fibrin Sealants
    • Collagen Based Adhesives
    • Gelatin Based Adhesives
    • Others
  • Synthetic and Semi Synthetic Adhesives and Sealants
    • Cyanoacrylates
    • Polymeric Hydrogels
    • Urethane Based Adhesives
    • Others
By Indication
  • Tissue Sealing
  • Tissue Engineering
  • Hemostasis
By End User
  • Hospitals
  • Clinics
  • Others
By Application
  • Central Nervous System
  • Cardiovascular
  • General surgery
  • Orthopedic
  • Cosmetic
  • Pulmonary
  • Urology
  • Ophthalmology
  • Others
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, 
    Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Surgical Sealants and Adhesives Market

  1. MIS Laparoscopic Procedure Growth Driving Haemostatic and Tissue Adhesive Sealant Demand:MIS growth drives MIS surgical sealant demand from Baxter, Ethicon, Medtronic, and laparoscopic sealant supply.
  2. Cardiovascular TAVI, CABG, and Aortic Surgery Driving Fibrin and Cardiac Sealant Demand:Cardiac surgery drives cardiovascular surgery sealant demand from Baxter Tisseel, CryoLife BioGlue, and cardiac sealant supply.
  3. Pulmonary Lobectomy Air Leak Prevention Driving PEG Hydrogel Sealant for Lung Parenchyma:Pulmonary air leak prevention drives pulmonary air leak sealant demand from Cohesion, Baxter, and pulmonary sealant supply.
  4. Spinal and Neurosurgical Dural Closure CSF Leak Prevention Driving PEG Sealant Demand:Dural closure CSF prevention drives dural closure sealant demand from Integra, Baxter, and dural sealant supply.
  5. Cyanoacrylate Tissue Adhesive Replacing Sutures in Emergency and Elective Skin Closure:Tissue adhesive wound closure drives tissue adhesive wound closure demand from Ethicon Dermabond, Closure Medical, and tissue adhesive supply.
  6. Robotic Surgery Da Vinci Platform Driving Robotics-Compatible Sealant Applicator Demand:Robotic surgery sealant drives robotic surgery sealant demand from Baxter, Ethicon, and robotics-compatible supply.

Regional Outlook: Surgical Sealants and Adhesives Market

Competitive Landscape: Surgical Sealants and Adhesives Market

Surgical Sealants and Adhesives Market Forecast 2035 — Key Industry Participants

  • Fibrin Sealant Manufacturers:Baxter, CSL Behring, Grifols, and https://www.omrix.com are the leading fibrin sealant manufacturers competing on haemostasis time, fibrin clot strength, thrombin and fibrinogen concentration, recombinant versus plasma-derived sourcing, pathogen inactivation step, and cardiovascular and liver surgery fibrin sealant regulatory approval and hospital formulary listing.
  • PEG Hydrogel Sealant Suppliers:Cohesion Technologies, Baxter, Integra LifeSciences, and Tissuemed are the leading PEG hydrogel sealant suppliers competing on burst pressure resistance of sealed tissue, biodegradation time, flexibility and compliance on lung parenchyma, swelling ratio in CSF environment, FDA 510(k) and CE mark dural and pulmonary sealant regulatory approval.
  • Cyanoacrylate Tissue Adhesive Suppliers:Ethicon, Chemence, Closure Medical, and B.Braun are the leading tissue adhesive suppliers competing on film flexibility and crack resistance on dynamic skin, wound tensile strength versus 4-0 suture, biodegradation profile, microbial barrier properties, paediatric wound safety, and FDA 510(k) and CE topical tissue adhesive regulatory clearance for skin closure product supply.
  • Albumin-Glutaraldehyde and Specialty Surgical Adhesive Suppliers:CryoLife, Terumo, Baxter, and Medtronic are the leading albumin-glutaraldehyde and specialty surgical adhesive suppliers competing on bond strength to aortic tissue, initial haemostasis time, cytotoxicity profile, aortic wall tissue reinforcement, and cardiovascular and aortic surgery specialty surgical adhesive regulatory approval and cardiac surgical society guideline recommendation.
  • Haemostatic Sealant and Topical Haemostasis Suppliers:Baxter, Ethicon, Medtronic, and BD Bard are the leading haemostatic sealant suppliers competing on haemostasis time in active arterial bleeding model, matrix biocompatibility, resorbability timeline, applicator design for laparoscopic access, and surgical haemostasis regulatory clearance across surgical specialties.
  • Surgical Sealant Delivery Device and Applicator Suppliers:Baxter, Ethicon, Medtronic, and https://www.cardium.com are the leading sealant delivery device suppliers competing on laparoscopic applicator working channel diameter, spray pattern uniformity, endoscopic length, activation simplicity in surgical field, and robotic surgery instrument compatibility for surgical sealant and tissue adhesive precise applicator supply.
  • Surgical Sealant Standard and Regulatory Bodies:FDA, https://www.ema.europa.eu, ISO, and ASTM are the leading surgical sealant regulatory and standard bodies establishing FDA Class III PMA premarket approval for fibrin sealant and most PEG surgical sealants, EMA centralised evaluation and EU MDR Class III regulatory pathway for surgical sealant and adhesive, ISO 13485 quality management system for surgical sealant manufacture, and ASTM F2458 wound closure adhesion and F2249 dural sealant test methods for surgical sealant regulatory submission and clinical performance documentation.

Consultant POV

“The surgical sealants and adhesives market is defined by clinical performance, regulatory approval, and surgical society endorsement — a product without a credible clinical evidence base does not get into the operating room regardless of cost. Baxter is the dominant global leader with Tisseel fibrin sealant and Floseal haemostatic matrix as the two most widely used haemostatic products in cardiovascular and general surgery. Ethicon Dermabond owns the topical skin closure market. CryoLife BioGlue has a protected niche in aortic surgery where albumin-glutaraldehyde tissue reinforcement is clinically proven. The highest-growth opportunity is laparoscopic and robotic surgery sealants — as procedure volumes grow and surgeons adopt precision applicator technology, every new robotic platform is a potential distribution channel for tissue sealant at premium pricing.”

Request Sample
Speak with an Analyst
Download TOC

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

More Press Releases

Speak with an Analyst

    Download TOC

      Request a Sample Report